Vertical Deals in Healthcare: Key Antitrust Takeaways for Private Equity Firms
By EsqSocial Corporation 25/02/21
As it continues to grapple with the COVID-19 pandemic, the healthcare sector will face increased antitrust scrutiny from the Biden administration, with the Federal Trade Commission (the “FTC”) and Department of Justice, Antitrust Division (the “DOJ”) (together the “Agencies”) as the Agencies ramp up their reviews not just of “horizontal” transactions (i.e., deals between competitors), but also of “vertical” transactions (i.e., deals that combine market participants at different levels of the...
By: Sheppard Mullin Richter & Hampton LLP